Clinical Trial Update: The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the movement of botulinum toxin through the lateral gastrocnemius muscle in humans for stroke-related muscle spasticity; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Stroke

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Stroke, Muscle Spasticity | Phase 4 | Status: TERMINATED | Results posted: 2021-12-29